Version 2 2020-04-07, 16:01Version 2 2020-04-07, 16:01
Version 1 2020-04-07, 16:00Version 1 2020-04-07, 16:00
journal contribution
posted on 2020-04-07, 16:01authored byCP Nelson, V Codd
The relationship of telomere length with cancer risk has been the source of much debate within epidemiological studies, which have produced inconsistent finding both between and within different cancer types. Over recent years, genome-wide association studies of increasing size have identified variants that determine human telomere length. These variants have subsequently been utilised as instrumental variables in Mendelian randomisation based studies, allowing the investigation of potential causal relationships between telomere length and cancer. Here we discuss recent advances in both genomic discovery, studies that give increasing evidence towards a causal role for telomere length in cancer risk and considerations for future studies.
History
Citation
Current Opinion in Genetics and Development 2020, 60:63–68